Proteolysis and cell migration: Creating a path?

Current Opinion in Cell Biology

Volumn 11, Issue 5, 1999, Pages 614-621

  Murphy, Gillian ^a   Gavrilovic, Jelena ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; INTEGRIN; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; SERINE PROTEINASE; UROKINASE;

CELL MIGRATION; CELL SURFACE; CYTOSKELETON; EXTRACELLULAR MATRIX; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

EID: 0032820711     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(99)00022-8     Document Type: Review

References (68)

1. Lauffenburger DA, Horwitz AF Cell migration: a physically integrated molecular process. Cell. 84:1996;359-369.
2. Friedl P, Zanker KS, Brocker EB Cell migration strategies in 3-D extracellular matrix: differences in morphology, cell matrix interactions, and integrin function. Microsc Res Tech. 43:1998;369-378.
3. Andreasen PA, Kjoller L, Christensen L, Duffy MJ The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer. 72:1997;1-22.
4. Basbaum CB, Werb Z Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol. 8:1996;731-738.
5. Gilles C, Polette M, Seiki M, Birembaut P, Thompson EW Implication of collagen type 1-induced membrane-type 1 matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab Invest. 76:1997;651-660.
6. Tomasek JJ, Halliday NL, Updike DL, Ahern-Moore JS, Vu TKH, Liu RW, Howard EW Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J Biol Chem. 272:1997;7482-7487.
7. Deryugina EI, Bourdon MA, Reisfeld RA, Strongin A Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res. 58:1998;3743-3750. Overexpression of MT1 MMP and consequent binding and activation of MMP2 promotes tumour cell ability to contract a collagen I gel. The MMP2 hemopexin domain and TIMP2, but not TIMP1, prevented gel contraction.
8. Haas TL, Davis SJ, Madri JA Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J Biol Chem. 273:1998;3604-3610.
9. Kheradmand F, Werner E, Tremble P, Symons M, Werb Z Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change. Science. 280:1998;898-902. MMP1 upregulation during integrin and hence cytoskeletal disruption of fibroblasts is regulated via Racl, reactive oxygen and autocrine action of interleukin-1.
10. Lambert CA, Lapiere CM, Nusgens BW An interleukin-1 loop is induced in human skin fibroblasts upon stress relaxation in a three-dimensional collagen gel but is not involved in the up-regulation of matrix metalloproteinase 1. J Biol Chem. 273:1998;23143-23149.
11. Ravanti L, Heino J, Pez O, Ri VM Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase. J Biol Chem. 274:1999;2446-2455.
12. Ellerbroek SM, Fishman DA, Kearns AS, Bafetti LM, Stack MS Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through β1 integrin. Cancer Res. 59:1999;1635-1641.
13. Chapman HA Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol. 9:1997;714-724.
14. Bajou K, Noël A, Gerard RD, Masson V, Brunner N, Holst-Hansen C, Skobe M, Fusenig NE, Carmeliet P, Collen D, Foidart JM Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med. 4:1998;923-928. PAI-1 deficient mice do not support malignant keratinocyte invasion and tumour vascularisation in a model system. Administration of an adenoviral vector expressing PAI-1 restores both invasion and associated angiogenesis.
15. Noel A, Gilles C, Bajou K, Devy L, Kebers F, Lewalle JM, Maquoi E, Munaut C, Remacle A, Foidart JM Emerging roles for proteinases in cancer. Invasion Metastasis. 17:1997;221-239.
16. Ellerbroek SM, Hudson LG, Stack MS Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion. Int J Cancer. 78:1998;331-337.
17. Kim J, Yu W, Kovalski K, Ossowski L Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell. 94:1998;353-362.
18. Rosenthal EL, Johnson TM, Allen ED, Apel IJ, Punturieri A, Weiss SJ Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells. Cancer Res. 58:1998;5221-5230.
19. Carmeliet P, Collen D Development and disease in proteinase deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system. Thromb Res. 91:1998;255-285. This review covers all the recent studies on disease models in proteinase-deficient mice. Notable are the unpredictable effects of the PA system gene ablations on atherosclerosis models.
20. Carmeliet P, Moons L, Dewerchin M, Rosenburg S, Herbert JM, Lupu F, Collen D Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vasular wound healing in mice. J Cell Biol. 140:1998;233-245. uPAR deficiency does not impair migration of smooth muscle cells in vitro or in vivo. Plasmin function in terms of fibrinolysis was also normal, apparently as a result of accumulation of uPA in the pericellular space.
21. Forough R, Koyama N, Hasenstab D, Lea H, Clowes M, Nikkari ST, Clowes AW Overexpression of tissue inhibitor of matrix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Circ Res. 79:1996;812-820.
22. Cheng L, Mantile G, Pauly R, Nater C, Felici A, Monticone R, Bilato C, Gluzband YA, Crow MT, Stetler-Stevenson W, Capogrossi MC Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. Circulation. 98:1998;2195-2201.
23. George SJ, Johnson JL, Angelini GD, Newby AC, Baker AH Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein. Hum Gene Ther. 9:1998;867-877.
24. George SJ, Baker AH, Angelini GD, Newby AC Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins. Gene Ther. 5:1998;1552-1560.
25. Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell. 95:1998;365-377. Muscle explants from PA- or plasminogen-deficient mice neovascularise fibrin gels using MMPs. MT1 MMP is implicated because cells overexpressing this gene rapidly invade fibrin gels.
26. Lochter A, Srebrow A, Sympson CJ, Terracio N, Werb Z, Bissell MJ Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties. J Biol Chem. 272:1997;5007-5015.
27. Lochter A, Navre M, Werb Z, Bissell MJ α1 and α2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression. Mol Biol Cell. 10:1999;271-282.
28. Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol. 139:1997;1861-1872.
29. Shipley JM, Wesselschmidt RL, Kobayashi DK, Ley TJ, Shapiro SD Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci USA. 93:1996;3942-3946.
30. Vaalamo M, Kariniemi AL, Shapiro SD, Saarialho-Kere U Enhanced expression of human metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration. J Invest Dermatol. 112:1999;499-505.
31. Knäuper V, Murphy G Membrane-type matrix metalloproteinases and cell surface-associated activation cascades for matrix metalloproteinases. Parks WC, Mecham RP Matrix metalloproteinases. 1998;199-218 Academic Press, San Diego.
32. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI Mechanism of cell surface activation of 72 kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem. 270:1995;5331-5338.
33. Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, Van Westrum SS, Crabbe T, Clements J, D'ortho M-P, Murphy G The TIMP2 membrane type 1 metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A. J Biol Chem. 273:1998;871-880.
34. Stanton H, Gavrilovic J, Atkinson SJ, D'ortho MP, Yamada KM, Zardi L, Murphy G The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J Cell Sci. 111:1998;2789-2798.
35. Lehti K, Lohi J, Valtanen H, Keski-Oja J Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem J. 334:1998;345-353.
36. Pei DQ, Weiss SJ Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem. 271:1996;9135-9140.
37. D'ortho M-P, Will H, Atkinson S, Butler GS, Messant A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem. 250:1997;751-757.
38. Beliën ATJ, Paganetti PA, Schwab ME Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J Cell Biol. 144:1999;373-384.
39. Nakahara H, Howard L, Thompson EW, Sato H, Seiki M, Yeh YY, Chen WT Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci USA. 94:1997;7959-7964.
40. Urena JM, Merlos-Suarez A, Baselga J, Arribas J The cytoplasmic carboxy-terminal amino acid determines the subcellular localization of proTGF-(alpha) and membrane type matrix metalloprotease (MT1-MMP). J Cell Sci. 112:1999;773-784. This is the first indication of an intracellular trafficking mechanism for MT1 MMP in conjunction with [41-43]; a number of avenues of investigation have, opened up.
41. Fernandez-Larrea J, Merlos-Suarez A, Urena JM, Baselga J, Arribas J A role for a PDZ protein in the early secretory pathway for the targeting of proTGF-α to the cell surface. Mol Cell. 3:1999;423-433.
42. Grootjans JJ, Zimmermann P, Reekmans G, Smets A, Degeest G, Durr J, David G Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc Natl Acad Sci USA. 94:1997;13683-13688.
43. Granes F, Garcia R, Casaroli-Marano RP, Castel S, Rocamora N, Reina M, Urena JM, Vilaro S Syndecan-2 induces filopodia by active Cdc42Hs. Exp Cell Res. 248:1999;439-456.
44. Blavier L, Delaissé JM Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J Cell Sci. 108:1995;3649-3659.
45. Sato T, Foged NT, Delaisse JM The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors. J Bone Miner Res. 13:1998;59-66.
46. Sato T, Ovejero MD, Hou P, Heegaard AM, Kumegawa M, Foged NT, Delaissé JM Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. J Cell Sci. 110:1997;589-596.
47. Cockett MI, Murphy G, Birch ML, O'Connell JP, Crabbe T, Millican AT, Hart IR, Docherty AJP Matrix metalloproteinases and metastatic cancer. Biochem Soc Symp. 63:1997;295-313.
48. Brooks PC, Silletti S, Von Schalscha TL, Friedlander M, Cheresh DA Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell. 92:1998;391-400.
49. Graesser D, Mahooti S, Haas T, Davis S, Clark RB, Madri JA The interrelationship of α4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis. Lab Invest. 78:1998;1445-1458.
50. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58:1998;1048-1051. MMP2-deficient mice show reduced rates of angiogenesis and experimental tumour growth.
51. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 93:1998;411-422. MMP9-deficient mice exhibit an abnormal pattern of growth plate vascularisation, possibly as a result of delayed release of an angiogenic activator.
52. Legrand C, Gilles C, Zahm J-M, Polette M, Buisson A-C, Kaplan H, Birembaut P, Tournier J-M Airway epithelial cell migration dynamics: MMP9 role in cell-extracellular matrix remodeling. J, Cell Biol. 146:1999;517-529. This paper elegantly demonstrates that both collagen IV and MMP9 colocalise in lamellipodia and are needed for efficient cell migration. MMP9-deficient mice exhibit an abnormal pattern of growth plate vascularisation, possibly as a result of delayed release of an angiogenic activator.
53. Olson MW, Toth M, Gervasi DC, Sado Y, Ninomiya Y, Fridman R High affinity binding of latent matrix metalloproteinase-9 to the α2(IV) chain of collagen IV. J Biol Chem. 273:1998;10672-10681. The binding of proMMP9 to MCF10A cells via single chain α2IV collagen is identified.
54. Partridge CA, Phillips PG, Niedbala MJ, Jeffrey JJ Localization and activation of type IV collagenase/gelatinase at endothelial focal contacts. Am J Physiol Lung Cell Mol Physiol. 272:1997;L813.
55. Ginestra A, Monea S, Seghezzi G, Dolo V, Nagase H, Mignatti P, Vittorelli ML Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. J Biol Chem. 272:1997;17216-17222.
56. 3,8-10 is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol. 176:1998;206-215. Specific CD44 isoforms bearing heparan sulphate side chains are involved in invadopodia formation, matrix degradation and migration in tumour cells. Both CD44 and MMP9 are colocalised in invadopodia.
57. Yu Q, Stamenkovic I Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 13:1999;35-48. Specific CD44 isoforms expressed on tumour cells are associated with MMP9 when clustered by hyaluronan interactions. CD44-associated active MMP9 promotes collagen IV degradation and tumour cell invasion of myoblast monolayers.
58. Takahashi C, Sheng ZQ, Horan TP, Kitayama H, Maki M, Hitomi K, Kitaura Y, Takai S, Sasahara RM, Horimoto Aet al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA. 95:1998;13221-13226.
59. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V., Induction of, cell migration, by matrix, metalloprotease-2 cleavage, of laminin-5 Science. 277:1997;225-228.
60. Bedi KS, Winter J, Berry M, Cohen J Adult rat dorsal root ganglion neurons extend neurites on predegenerated but not on normal peripheral nerves in vitro. Euro J Neuroscience. 4:1991;193-200.
61. Zuo J, Ferguson TA, Hernandez YJ, Stetler-Stevenson WG, Muir D Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J Neurosci. 18:1998;5203-5211.
62. Pilcher BK, Dumin JA, Sudbeck BD, Krane SM, Welgus HG, Parks WC The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol. 137:1997;1445-1457.
63. 1 integrin-mediated cell adhesion. J Cell Sci. 111:1998;1127-1135.
64. Dumin JA, Dickeson K, Goldberg G, Santoro SA, Parks WC Interaction among collagenase-1, collagen, and the integrin α2β1 during re-epithelialization. Invest Dermatol. 112:1999;536.
65. RhoGAP and membrane-protrusive activities at invadopodia. J Biol Chem. 273:1998;9-12.
66. Mueller SC, Ghersi G, Akiyama SK, Sang Q-X, Howard L, Pineiro-Sanchez M, Nakahara H, Yeh Y, Chen W-T. A novel protease-docking function of integrin at invadopodia. J Biol Chem. 274:1999;24947-24952.
67. Lottaz D, Maurer CA, Hahn D, Buchler MW, Sterchi EE Nonpolarized secretion of human meprin alpha in colorectal cancer generates an increased proteolytic potential in the stroma. Cancer Res. 9:1999;1127-1133.
68. Pöllänen J, Saksela O, Salonen E-M, Andreasen PA, Nielson LS, Daro K, Vaheri A Distinct localisations of urokinase-type plasminogen activator and its type I inhibitor under cultured human fibroblasts and sarcoma cells. J Cell Biol. 104:1987;1085-1096.